Detalles de la búsqueda
1.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443899
2.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Cancers (Basel)
; 15(7)2023 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046641
3.
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Crit Rev Oncol Hematol
; 180: 103848, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257536
4.
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.
Target Oncol
; 17(4): 467-474, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35751733
5.
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region.
Clin Genitourin Cancer
; 17(1): e187-e194, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30448106
6.
The role of systemic and targeted therapies in brain metastases.
Expert Rev Anticancer Ther
; 14(1): 93-103, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24308678
7.
Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
J Clin Oncol
; 30(19): 2362-8, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22585698
Resultados
1 -
7
de 7
1
Próxima >
>>